Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatocellular carcinoma.

Luis J Lopez1, Jorge A Marrero

  • 1San Juan VA Medical Center, San Juan, Puerto Rico.

Current Opinion in Gastroenterology
|February 11, 2005
PubMed
Summary
This summary is machine-generated.

Hepatocellular carcinoma (HCC) is increasing globally. Obesity is a key risk factor, and Glypican-3 shows promise as an early detection marker for HCC, enabling timely treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review.

Gastroenterology·2026
Same author

Validation of Texas Hepatocellular Carcinoma Consortium Risk Index in the Hepatocellular Carcinoma Early Detection Strategy Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Shifts in Cohort Eligibility With Deimplementation of Race-specific Guidance for Hepatocellular Carcinoma Surveillance.

Gastro hep advances·2025
Same author

HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort.

Journal of hepatology·2025
Same author

Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.

Hepatology (Baltimore, Md.)·2025
Same author

AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease.

Hepatology (Baltimore, Md.)·2025
Same journal

Neuroendocrine tumors of the stomach and duodenum: evolving classification, endoscopic management, and surveillance.

Current opinion in gastroenterology·2026
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
See all related articles

Area of Science:

  • Hepatology
  • Oncology
  • Medical Imaging

Background:

  • Hepatocellular carcinoma (HCC) incidence and research publications are rising.
  • Hepatitis C-related HCC is projected to increase, mirroring the Japanese epidemic.
  • Non-alcoholic fatty liver disease (NAFLD) and obesity are significant risk factors for HCC development.

Purpose of the Study:

  • To review recent advancements in hepatocellular carcinoma (HCC) research.
  • To highlight key findings in HCC etiology, detection, and treatment.

Main Methods:

  • Review of current literature on HCC.
  • Analysis of epidemiological trends and molecular studies.
  • Evaluation of diagnostic markers and therapeutic interventions.

Related Experiment Videos

Main Results:

  • Hepatitis C-related HCC expected to rise for two decades.
  • Obesity identified as a critical risk factor for HCC.
  • Glypican-3 demonstrates potential as a novel HCC tumor marker.
  • Dynamic gadolinium MRI is the preferred imaging modality for HCC evaluation.
  • Liver transplantation remains the primary treatment; transarterial chemoembolization and radiofrequency ablation improve survival in non-surgical cases.

Conclusions:

  • Early detection of HCC is crucial due to rising incidence.
  • Identifying at-risk populations, particularly those with obesity, is paramount.
  • Glypican-3 and understanding obesity's role represent significant progress in early HCC detection and management.